Ali Andalibi, Ph.D.
Associate Dean for Research, College of Science, George Mason University
Inflammatory diseases – genetics and drug discovery. More →
Milton Brown, M.D., Ph.D.
Director, Inova Center for Drug Discovery and Development
Experimental therapeutics for cancer.
Umesh Desai, Ph.D.
Professor, Institute for Structural Biology, Drug Discovery & Development, Virginia Commonwealth University
Glycosaminoglycans and mimetics as modulators of coagulation, cancer, inflammation, emphysema and viral infection
Marion Ehrich, R.Ph., Ph.D., DABT, ATS
Professor of Pharmacology/Toxicology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, and Virginia Tech School of Medicine
Paul B. Fisher, M.Ph., Ph.D., FNAI
Professor and Chair, Department of Human and Molecular Genetics, VCU Director, VCU Institute of Molecular Medicine
Molecular determinants of cancer progression and metastasis, viral-based therapy of cancer (Cancer Terminator Viruses) and small molecule inhibitors of metastasis More →
B. Frank Gupton, Ph.D.
Chair and Professor, Department of Chemical and Life Science Engineering at VCU
Flow Chemistry, Catalysis, Active Pharmaceutical Ingredients More →
David G. I. Kingston, Ph.D., FRIC
University Distinguished Professor, Chemistry, Virginia Tech
Nanoparticle Drug Delivery, Natural Products as anticancer and antimalarial agents. More →
John Lazo, Ph.D.
Harrison Distinguished Professor of Pharmacology and Chemistry, Associate Director for Basic Science at the UVA Cancer Center, University of Virginia
Pharmacology, Chemical-Biology, Phosphatases, Cancer, Alzheimer’s disease. More →
Elizabeth Sharlow, Ph.D.
Associate Professor of Research, Department of Pharmacology; Co-Director, Fiske Drug Discovery Laboratory, University of Virginia
Chemical Biology, Phosphatases, Cancer, High Throughput Screening, Assay Development